Natalie Charnley

607 total citations
32 papers, 295 citations indexed

About

Natalie Charnley is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Natalie Charnley has authored 32 papers receiving a total of 295 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pulmonary and Respiratory Medicine, 11 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Oncology. Recurrent topics in Natalie Charnley's work include Renal cell carcinoma treatment (18 papers), Cancer Genomics and Diagnostics (8 papers) and Medical Imaging Techniques and Applications (7 papers). Natalie Charnley is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Cancer Genomics and Diagnostics (8 papers) and Medical Imaging Techniques and Applications (7 papers). Natalie Charnley collaborates with scholars based in United Kingdom, France and United States. Natalie Charnley's co-authors include Pat Price, Azeem Saleem, Rachel Cooper, Ananya Choudhury, Michael Moran, Stephanie B. Donaldson, Kate Fife, David Sebag‐Montefiore, Dana J. Nickens and Omi Parikh and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Natalie Charnley

28 papers receiving 289 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Natalie Charnley United Kingdom	10	143	95	87	69	63	32	295
Petr Krivorotko Russia	8	132 0.9×	76 0.8×	213 2.4×	131 1.9×	94 1.5×	91	415
B.V. Offersen Denmark	4	160 1.1×	79 0.8×	50 0.6×	89 1.3×	133 2.1×	15	279
Cihang Bao China	11	112 0.8×	46 0.5×	110 1.3×	169 2.4×	118 1.9×	19	398
A. Biete Spain	9	119 0.8×	91 1.0×	147 1.7×	112 1.6×	93 1.5×	25	425
Suzanne C. van Es Netherlands	10	141 1.0×	228 2.4×	161 1.9×	125 1.8×	79 1.3×	14	400
Pooja Jain United Kingdom	11	293 2.0×	153 1.6×	182 2.1×	72 1.0×	99 1.6×	26	521
Simul Parikh United States	6	146 1.0×	37 0.4×	244 2.8×	79 1.1×	99 1.6×	9	362
WC Wood United States	4	136 1.0×	48 0.5×	226 2.6×	41 0.6×	129 2.0×	5	334
Özge Gümüşay Türkiye	11	124 0.9×	30 0.3×	164 1.9×	100 1.4×	78 1.2×	42	350
Honghai Dai China	11	236 1.7×	167 1.8×	136 1.6×	42 0.6×	17 0.3×	14	355

Countries citing papers authored by Natalie Charnley

Since Specialization

Citations

This map shows the geographic impact of Natalie Charnley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Natalie Charnley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Natalie Charnley more than expected).

Fields of papers citing papers by Natalie Charnley

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Natalie Charnley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Natalie Charnley. The network helps show where Natalie Charnley may publish in the future.

Co-authorship network of co-authors of Natalie Charnley

This figure shows the co-authorship network connecting the top 25 collaborators of Natalie Charnley. A scholar is included among the top collaborators of Natalie Charnley based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Natalie Charnley. Natalie Charnley is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McCarthy, Elizabeth, Amy L. Chadwick, J.J. Soto Castillo, et al.. (2025). A multi-centre review of the use of adjuvant pembrolizumab for renal cell carcinoma.. Journal of Clinical Oncology. 43(5_suppl). 484–484.

Charnley, Natalie, Kate Fife, Daniel Y.C. Heng, et al.. (2025). Impact of brain metastases on systemic renal cell carcinoma treatment outcomes: A systematic literature review. Cancer Treatment Reviews. 140. 103024–103024.

McGrane, John, Amarnath Challapalli, Alison Clayton, et al.. (2024). Real world, multicentre patterns of treatment and survival in metastatic renal cell carcinoma with the UK Renal Oncology Collaborative (UK ROC): Is it time to look favourably on first‐line immunotherapy containing combinations in all IMDC groups?. Cancer Medicine. 13(12).

Brown, Janet E., et al.. (2024). Implications of bone metastasis on response to systemic therapy in patients with advanced renal cell carcinoma: A systematic literature review. Cancer Treatment Reviews. 129. 102792–102792. 2 indexed citations

Rossi, Sabrina H., Andrew Greaves, Maxine Tran, et al.. (2024). A decade long insight into patient views on kidney cancer care delivery. British Journal of Urology. 135(2). 243–245. 1 indexed citations

Rehan, Ahmed, Kate O’Connor, Maria Serra, et al.. (2024). Real world outcomes for maintenance avelumab treatment in locally advanced/metastatic urothelial cancer after platinum-based chemotherapy.. Journal of Clinical Oncology. 42(4_suppl). 584–584.

Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2024). Real-world Treatment Sequencing and Outcomes With Cabozantinib After First-line Immune Checkpoint Inhibitor-based Combination Therapy For Patients With Advanced Renal Cell Carcinoma: CARINA Study Results. Clinical Genitourinary Cancer. 22(5). 102141–102141. 1 indexed citations

Allison, Jennifer, Sam Wong, Helen Wong, et al.. (2023). Clinical Outcomes of Tivozanib Monotherapy as First-Line Treatment for Metastatic Renal Cell Carcinoma: A Multicentric UK Real-World Analysis. Targeted Oncology. 18(4). 593–599. 1 indexed citations

Nathan, Paul, Jennifer Allison, Natalie Charnley, et al.. (2023). Real-world treatment sequencing and outcomes for patients with advanced renal cell carcinoma treated with cabozantinib after first-line checkpoint inhibitor-based combination therapy: Results from the CARINA study.. Journal of Clinical Oncology. 41(16_suppl). e16512–e16512. 2 indexed citations

10.

Challapalli, Amarnath, John McGrane, Sarah Kingdon, et al.. (2022). 1457P A UK multicentre retrospective review of metastatic renal cell carcinoma (mRCC) patients (pts) outcomes with brain metastases (BM) in the modern era. Annals of Oncology. 33. S1211–S1211. 2 indexed citations

11.

Allison, Jennifer, Natalie Charnley, Robert B. Stevenson, Tom Waddell, & Manon Pillai. (2021). Axitinib and avelumab (AA) as first-line treatment of metastatic renal cell carcinoma (mRCC): A real-world outcome review in the Northwest of England, United Kingdom.. Journal of Clinical Oncology. 39(6_suppl). 294–294. 2 indexed citations

12.

Moran, Michael, et al.. (2019). Sunitinib for Metastatic Renal Cell Carcinoma: A Systematic Review and Meta-Analysis of Real-World and Clinical Trials Data. Targeted Oncology. 14(4). 405–416. 43 indexed citations

13.

Walker, Matthew, Julian C. Matthews, Charles C. Watson, et al.. (2010). Development and validation of a variance model for dynamic PET: uses in fitting kinetic data and optimizing the injected activity. Physics in Medicine and Biology. 55(22). 6655–6672. 4 indexed citations

14.

Price, Pat, C. L. Dickinson, Natalie Charnley, et al.. (2009). A PET imaging study of the vascular disruptive agent OXi4503 to confirm in vivo mechanism of action in a phase I trial. Journal of Clinical Oncology. 27(15_suppl). e14510–e14510. 1 indexed citations

15.

Walker, Matthew, Julian C. Matthews, Marie-Claude Asselin, et al.. (2009). Optimization of the Injected Activity in Dynamic 3D PET: A Generalized Approach Using Patient-Specific NECs as Demonstrated by a Series of¹⁵O-H₂O Scans. Journal of Nuclear Medicine. 50(9). 1409–1417. 16 indexed citations

16.

Charnley, Natalie, Stephanie B. Donaldson, & Pat Price. (2008). Angiogenic Signalling Pathways. Methods in molecular biology. 467. 25–51. 24 indexed citations

17.

Saleem, Azeem, Natalie Charnley, & Pat Price. (2006). Clinical molecular imaging with positron emission tomography. European Journal of Cancer. 42(12). 1720–1727. 24 indexed citations

18.

Charnley, Natalie, Catharine West, Graeme M. Bydder, et al.. (2006). Early change in glucose metabolic rate measured using FDG-PET in patients with high-grade glioma predicts response to temozolomide but not temozolomide plus radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 66(2). 331–338. 30 indexed citations

19.

Charnley, Natalie, Ashley M. Morgan, Evan Thomas, et al.. (2005). The use of CT-MR image registration to define target volumes in pelvic radiotherapy in the presence of bilateral hip replacements. British Journal of Radiology. 78(931). 634–636. 17 indexed citations

20.

Charnley, Natalie, et al.. (2005). Effective treatment of anal cancer in the elderly with low-dose chemoradiotherapy. British Journal of Cancer. 92(7). 1221–1225. 38 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact